TY - JOUR T1 - Rotaglide Total Knee Arthroplasty: A Long-Term Follow-up Study AU - Metsovitis, Stergios R. AU - Ploumis, Avraam L. AU - Chantzidis, Paraskevas T. AU - Terzidis, Ioannis P. AU - Christodoulou, Anastasios G. AU - Dimitriou, Christos G. AU - Tsakonas, Athanasios C. Y1 - 2011/05/04 N1 - 10.2106/JBJS.I.01702 JO - The Journal of Bone & Joint Surgery SP - 878 EP - 884 VL - 93 IS - 9 N2 - Background:  Mobile-bearing knee designs represent an alternative to conventional fixed-bearing implants in total knee arthroplasty. The purpose of this study was to determine the clinical results of a mobile-bearing knee implant.Methods:  From 1990 to 1998, 326 primary consecutive mobile-bearing total knee prostheses were implanted in 260 patients who had a mean age and standard deviation of 66.7 ± 6.9 years. Femoral and tibial components were cemented in all knees, and the patella was resurfaced in 199 knees (61%). Patients were evaluated with the use of the Knee Society clinical rating system and radiographic examinations. Complications were noted, and survivorship of the prostheses was determined.Results:  The mean follow-up period was 156 ± 27.3 months, with maximum follow-up at eighteen years. The mean Knee Society knee score improved from 32.4 ± 21.2 preoperatively to 92.6 ± 10.0 at the time of the last follow-up (p = 0.00), and the mean Knee Society functional score improved from 39.3 ± 18.7 preoperatively to 66.7 ± 18.6 at the time of the last follow-up (p = 0.00). Mean knee flexion improved from 92.3° ± 14.5° preoperatively to 112.1° ± 13.4° at the time of the last follow-up (p = 0.00). There were twenty-four (7.4%) knees that required revision. In eighteen (5.5%) knees, worn out or broken polyethylene was found and a polyethylene-only exchange was done. Six knees (1.8%) were fully revised. The survival rate was 0.96 (95% confidence interval, 0.93 to 0.98) at ten years and 0.87 (95% confidence interval, 0.79 to 0.93) at eighteen years.Conclusions:  A fully congruent, mobile-bearing total knee prosthesis had excellent survivorship during the ten to eighteen-year follow-up interval.Level of Evidence:  Therapeutic Level IV. See Instructions to Authors for a complete description of levels of evidence. SN - 0021-9355 M3 - doi: 10.2106/JBJS.I.01702 UR - http://dx.doi.org/10.2106/JBJS.I.01702 ER -